LEMTRADA
NDC 58468-0200, ALEMTUZUMAB, injection, solution, concentrate, from Genzyme Corporation.
- Product NDC
- 58468-0200
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103948
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALEMTUZUMAB12 mg/1.2mL
Pharmacologic classes
CD52-directed Antibody Interactions [MoA]; CD52-directed Cytolytic Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-0200-1 | 58468020001 | 1 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1) / 1.2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6236b0bc-82e9-4447-9a78-f57d94770269Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=58468-0200
Use it
Look up 58468-0200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-0200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.